共 32 条
[4]
BODDE HE, 1989, INT S PRESENT DEV FU
[5]
BOLTON S, 1990, PHARM STATISTICS PRA, P117
[6]
FACTORS TO BE CONSIDERED IN THE EVALUATION OF BIOAVAILABILITY AND BIOEQUIVALENCE OF TOPICAL FORMULATIONS
[J].
SKIN PHARMACOLOGY,
1992, 5 (03)
:129-145
[8]
Brain K.R., 1993, PHARM SKIN PENETRATI, P389
[9]
CHIEN YW, 1982, NOVEL DRUG DELIVERY, P551
[10]
Collier S.W., 1992, PHARM SKIN, P111